123 related articles for article (PubMed ID: 11068992)
1. Sebaceous carcinoma of the eyelids: frequent expression of c-erbB-2 oncoprotein.
Cho KJ; Khang SK; Koh JS; Chung JH; Lee SS
J Korean Med Sci; 2000 Oct; 15(5):545-50. PubMed ID: 11068992
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of cyclooxygenase 2 and peroxisome proliferator-activated receptor γ in eyelid sebaceous gland carcinoma.
Jayaraj P; Sen S; Bhattacharya T; Arora J; Yadav S; Chhoker V; Kumar A; Dhanaraj PS; Yadavilli KS; Verma M
Histopathology; 2016 Aug; 69(2):268-75. PubMed ID: 26791964
[TBL] [Abstract][Full Text] [Related]
3. Expression of retinoic acid-binding proteins and retinoic acid receptors in sebaceous cell carcinoma of the eyelids.
Tsai YJ; Wu SY; Huang HY; Ma DH; Wang NK; Hsiao CH; Cheng CY; Yeh LK
BMC Ophthalmol; 2015 Oct; 15():142. PubMed ID: 26503156
[TBL] [Abstract][Full Text] [Related]
4. Does β-catenin have a role in pathogenesis of sebaceous cell carcinoma of the eyelid?
Jayaraj P; Sen S; Kashyap S; Sharma A; Pushker N; Bajaj MS; Ghose S; Chosdol K
Br J Ophthalmol; 2011 Feb; 95(2):284-7. PubMed ID: 20813740
[TBL] [Abstract][Full Text] [Related]
5. Expression of cell cycle regulatory proteins in eyelid sebaceous gland carcinoma: low p27 expression predicts poor prognosis.
Kim N; Kim JE; Choung HK; Lee MJ; Khwarg SI
Exp Eye Res; 2014 Jan; 118():46-52. PubMed ID: 24216315
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological features of considerable reduction in androgen receptor expression in sebaceous gland carcinoma of the eyelid.
Yunoki T; Miyakoshi A; Otsuka M; Hayashi A
Int Ophthalmol; 2019 Aug; 39(8):1703-1708. PubMed ID: 30027448
[TBL] [Abstract][Full Text] [Related]
7. ZEB2/SIP1 as novel prognostic indicator in eyelid sebaceous gland carcinoma.
Bhardwaj M; Sen S; Sharma A; Kashyap S; Chosdol K; Pushker N; Bajaj MS; Bakhshi S
Hum Pathol; 2015 Oct; 46(10):1437-42. PubMed ID: 26220160
[TBL] [Abstract][Full Text] [Related]
8. Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.
Schmitz EJ; Herwig-Carl MC; Holz FG; Loeffler KU
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2277-2285. PubMed ID: 28741159
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of the CDKN2A gene promoter is a frequent epigenetic change in periocular sebaceous carcinoma and is associated with younger patient age.
Liau JY; Liao SL; Hsiao CH; Lin MC; Chang HC; Kuo KT
Hum Pathol; 2014 Mar; 45(3):533-9. PubMed ID: 24440092
[TBL] [Abstract][Full Text] [Related]
10. Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid.
Kiyosaki K; Nakada C; Hijiya N; Tsukamoto Y; Matsuura K; Nakatsuka K; Daa T; Yokoyama S; Imaizumi M; Moriyama M
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):7-11. PubMed ID: 19628749
[TBL] [Abstract][Full Text] [Related]
11. Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin.
Jakobiec FA; Mendoza PR
Am J Ophthalmol; 2014 Jan; 157(1):186-208.e2. PubMed ID: 24112633
[TBL] [Abstract][Full Text] [Related]
12. Intraepithelial sebaceous carcinoma: a case report of an unusual occurrence.
Currie GP; Plaza JA; Harris GJ
Am J Dermatopathol; 2014 Aug; 36(8):673-6. PubMed ID: 24366199
[TBL] [Abstract][Full Text] [Related]
13. Correlation of the expression of telomerase RNA with risk factors for recurrence of sebaceous gland carcinoma.
Li B; Li N; Cheng G; Sun X; Xu X; Shi J; Li L; Chen C
Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):480-4. PubMed ID: 16133023
[TBL] [Abstract][Full Text] [Related]
14. Retinoid receptor subtypes in sebaceous cell carcinoma of the eyelid.
Chakravarti N; Saadati HG; El-Naggar AK; Lotan R; Diba RE; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2005 Jul; 21(4):292-7. PubMed ID: 16052143
[TBL] [Abstract][Full Text] [Related]
15. Sebaceous carcinoma of the eyelids: personal experience with 60 cases.
Shields JA; Demirci H; Marr BP; Eagle RC; Shields CL
Ophthalmology; 2004 Dec; 111(12):2151-7. PubMed ID: 15582067
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: comparison with histopathological parameter.
Hasebe T; Mukai K; Yamaguchi N; Ishihara K; Kaneko A; Takasaki Y; Shimosato Y
Mod Pathol; 1994 Jan; 7(1):37-43. PubMed ID: 7909154
[TBL] [Abstract][Full Text] [Related]
17. Sebaceous carcinoma. Tumor progression through mutational inactivation of p53.
Gonzalez-Fernandez F; Kaltreider SA; Patnaik BD; Retief JD; Bao Y; Newman S; Stoler MH; Levine PA
Ophthalmology; 1998 Mar; 105(3):497-506. PubMed ID: 9499782
[TBL] [Abstract][Full Text] [Related]
18. Merkel cell carcinoma co-existent with sebaceous carcinoma of the eyelid.
Tanahashi J; Kashima K; Daa T; Yada N; Fujiwara S; Yokoyama S
J Cutan Pathol; 2009 Sep; 36(9):983-6. PubMed ID: 19017040
[TBL] [Abstract][Full Text] [Related]
19. Programmed death receptor Ligand 1 expression in eyelid sebaceous carcinoma: a consecutive case series of 41 patients.
Xu S; Yu H; Fu G; Fan X; Jia R
Acta Ophthalmol; 2019 May; 97(3):e390-e396. PubMed ID: 29862664
[TBL] [Abstract][Full Text] [Related]
20. Common presentations of sebaceous gland carcinoma of the eyelid.
Wagoner MD; Beyer CK; Gonder JR; Albert DM
Ann Ophthalmol; 1982 Feb; 14(2):159-63. PubMed ID: 7092023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]